As per MRFR analysis, the US Obesity Management Market Size was estimated at 816.9 (USD Million) in 2023. The US Obesity Management Market Industry is expected to grow from 871.5(USD Million) in 2024 to 1,785 (USD Million) by 2035. The US Obesity Management Market CAGR (growth rate) is expected to be around 6.735% during the forecast period (2025 - 2035).
The US Obesity Management Market is shaped by several key market drivers that reflect the nation’s growing health concerns. With over 70% of American adults classified as overweight or obese, there is an increasing need for effective obesity management solutions. The rising recognition of obesity as a complex disease rather than a lifestyle choice has led to more comprehensive treatment approaches. Increasing focus on preventive measures, public health initiatives, and nutritional education programs further support this trend. Opportunities in this market can be found in the development of innovative weight-loss drugs and personalized nutrition plans tailored to individual needs.
Additionally, advances in digital health tools, including mobile applications and telehealth services, are expanding access to obesity management resources, making them more user-friendly and convenient for patients. In recent times, there has been a noticeable shift towards a multi-disciplinary approach in treating obesity, involving not only healthcare practitioners but also dietitians, psychologists, and fitness experts. This trend emphasizes holistic wellness strategies rather than relying solely on medications or surgical interventions. Moreover, the growth of community-based programs designed to tackle obesity through education and physical activity also highlights the concerted effort to address this public health challenge.
Other noteworthy trends include increased emphasis on mental health in the context of obesity, acknowledging its impact on weight management and the importance of psychological support in treatment plans. The rising demand for healthier food options and lifestyle change programs reflects the growing consumer awareness surrounding obesity and its health risks, creating a fertile ground for market expansion. Overall, these trends indicate a proactive stance towards managing obesity, making the US market increasingly dynamic and responsive to the needs of its population.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The escalating obesity rates in the United States significantly drive the US Obesity Management Market Industry. According to the Centers for Disease Control and Prevention (CDC), more than 42% of adults in the US were classified as obese in 2017-2018, marking a substantial increase from previous years. This uptick in obesity is linked to a higher prevalence of related health issues, including diabetes, heart disease, and certain cancers, which necessitate effective obesity management solutions. Major organizations such as the American Heart Association have consistently raised awareness regarding these alarming statistics, further stressing the need for targeted obesity management programs, including lifestyle interventions, pharmacotherapy, and surgical options. As a result, as more individuals seek solutions to manage their weight, the demand for obesity management products and services is expected to rise substantially, indicating strong growth prospects for the market.
Various governmental initiatives aimed at combating obesity significantly contribute to the growth of the US Obesity Management Market Industry. For example, the U.S. Department of Health and Human Services has launched programs such as 'Healthy People 2030', which sets benchmarks for health improvements, including a target to reduce obesity rates among adults and children. Initiatives like these not only create public awareness but also prompt increased funding and policy reforms focused on nutrition and physical activity. The commitment to improve community health outcomes by organizations like the Food and Drug Administration helps to stimulate investment in obesity management solutions, leading to market expansion.
Technological innovations in obesity management, including wearable fitness trackers and mobile health applications, are set to propel the US Obesity Management Market Industry forward. The Consumer Technology Association reported that 60% of U.S. adults were using some form of wearable technology to track their health in 2020. This interest in personal health management tools promotes adherence to weight management programs and enhances the overall effectiveness of these initiatives. Respected companies in the tech space, such as Fitbit, have been at the forefront of these innovations, allowing users to track their physical activity, diet, and weight, ultimately leading to better health outcomes. The continuous integration of technology in health management highlights a promising avenue for growth in the obesity management sector.
The US Obesity Management Market is witnessing significant growth with its diverse segmentation that includes Surgical Procedures, Pharmacotherapy, Lifestyle Changes, and Fitness Programs. Surgical Procedures, which comprise options such as bariatric surgery, play a crucial role in treating severe obesity and are often considered when other treatments have failed. This approach is critical as it often leads to substantial weight loss and improvement in associated health conditions such as diabetes and hypertension. On the other hand, Pharmacotherapy encompasses various medications designed to assist with weight loss by suppressing appetite or inhibiting fat absorption. This segment is essential in providing patients who are not candidates for surgery with options to manage their obesity more effectively.
Lifestyle Changes are also a vital category within the obesity management landscape, focusing on behavioral modifications through improved diet and physical activity. This segment emphasizes sustainable weight management practices, which are increasingly recognized for their long-term effectiveness in combating obesity. Lastly, Fitness Programs support individuals in their journey towards healthier lifestyles by promoting regular physical activity tailored to their specific needs.
This diversification in the US Obesity Management Market segmentation permits healthcare providers to adopt a multi-faceted approach in addressing the obesity crisis, driven by various factors including rising obesity rates, an increasing awareness of health risks, and a growing emphasis on preventative healthcare measures. With the combined efforts in addressing obesity via these distinct methods, the market demonstrates a strong potential for addressing one of the pressing health issues faced by the US population.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Obesity Management Market, with its focus on various End Users, demonstrates a dynamic landscape driven by growing health concerns related to obesity. Clinics and Hospitals play a crucial role, as they provide essential medical interventions and personalized care plans, which are vital for effective management of obesity. Home Care services have gained traction as they offer convenience and tailored solutions for obese patients, accommodating those who prefer treatments in a familiar environment. Fitness Centers contribute significantly by promoting active lifestyles and weight management through structured fitness programs and nutritional guidance.
As obesity rates continue to rise in the US, driven by sedentary lifestyles and unhealthy eating habits, these End User segments are expected to adapt and innovate, enhancing their services to meet the demands of the population. The growing awareness of obesity-related health complications reinforces the importance of these segments, as they are critical in the prevention and treatment of obesity, making their roles central to the overall success of obesity management efforts within the market.
The Treatment Method segment of the US Obesity Management Market is a critical area focused on diverse approaches to tackle obesity, a condition affecting a substantial portion of the population. Among the various methods, Bariatric Surgery has gained considerable recognition for its effectiveness in achieving significant weight loss and improving comorbidities associated with obesity, making it an essential option for patients who have not succeeded with alternative treatments. Pharmaceuticals represent another vital approach, offering an array of medications that assist in weight management and appetite control, thus catering to the needs of those who may not qualify for surgery or prefer non-invasive methods.
Nutritional Counseling plays a significant role in educating individuals about healthy eating habits, which is crucial in preventing obesity through lifestyle changes. Additionally, Behavioral Therapy emphasizes changing unhealthy habits and establishing a supportive environment for weight management, addressing the psychological aspects of obesity. Collectively, these methods highlight the multifaceted nature of obesity treatment, demonstrating a robust response to an ongoing public health challenge in the United States, where obesity rates have risen significantly over the years. As the US focuses on improving health outcomes, understanding the variations within the Treatment Method segment will be key to tailoring effective interventions for different patient needs.
The Distribution Channel segment within the US Obesity Management Market encompasses diverse avenues such as Online Pharmacies, Retail Pharmacies, Hospitals, and Direct Sales. Online Pharmacies have gained traction due to their convenience and growing consumer preference for remote access to health solutions, enhancing patient compliance. Retail Pharmacies remain a key player, offering immediate access to obesity management medications and promoting patient engagement through personalized healthcare services. Hospitals play a critical role by integrating obesity management programs into broader patient care, addressing systemic health issues while providing specialized support.
Direct Sales capitalize on personal interactions, enabling providers to deliver tailored solutions directly to consumers. The segment's evolution is driven by increasing obesity rates, shifting consumer behaviors, and advancements in telehealth solutions. Emerging technology in the healthcare sector, particularly digital platforms, is expected to redefine how patients access and manage obesity treatments, shaping the landscape of the US Obesity Management Market. Moreover, rising health awareness and preventive care trends significantly influence consumer choices in selecting suitable distribution channels, thereby fueling the market growth.
The US Obesity Management Market has been experiencing significant growth driven by the increasing prevalence of obesity and related health issues among the population. The competitive landscape is characterized by the presence of numerous pharmaceutical companies and healthcare providers that are actively investing in the development of innovative treatments and solutions for obesity management. With various therapeutic approaches, including pharmacotherapy, behavioral interventions, and surgical options, the market has become an attractive arena for stakeholders. Companies are focusing on advancing their product pipelines and leveraging strategic collaborations to enhance their market presence. As awareness around obesity continues to rise, driven by public health initiatives and evolving consumer perspectives, organizations are increasingly aligning their strategies to cater to the diverse needs of patients across the United States.
Bristol Myers Squibb has established itself as a formidable player in the US Obesity Management Market. The company benefits from its robust research and development capabilities, which enable it to explore novel obesity treatment options tailored for various patient demographics. Its strong reputation and longstanding presence in the pharmaceutical industry have allowed Bristol Myers Squibb to foster collaborative relationships with healthcare providers and institutions. This collaborative approach facilitates the integration of clinical insights into the development process, ensuring that the therapies meet real-world needs. The company’s focus on patient-centered care and dedication to improving outcomes for individuals with obesity positions it favorably in the competitive landscape, solidifying its commitment to addressing this pressing health issue.
Eli Lilly is another key entity in the US Obesity Management Market, recognized for its innovative pharmaceuticals aimed at weight management. The company has made significant strides with its key products that target obesity, focusing on science-backed solutions that cater to a diverse patient base. Eli Lilly's established market presence, bolstered by a comprehensive marketing strategy, has allowed it to effectively reach and engage healthcare professionals and patients alike. The company’s strengths lie in its commitment to research and development, leading to a consistent pipeline of new treatments. Moreover, Eli Lilly has been proactive in expanding its portfolio through strategic mergers and acquisitions, enhancing its ability to offer cutting-edge therapies that address obesity and its comorbidities. This approach not only strengthens the company’s foothold in the obesity treatment market segment but also underscores its dedication to mitigating the obesity epidemic in the United States.
Recent developments in the US Obesity Management Market indicate significant growth driven by increased awareness of obesity's health impacts. Companies like Bristol Myers Squibb and Eli Lilly are actively expanding their portfolios with innovative solutions, such as weight management drugs and comprehensive care plans. Recently, in September 2023, Eli Lilly announced the acquisition of a promising obesity drug platform, enhancing its competitive position in the market. Novo Nordisk continues to advance its obesity treatments, recently reporting a substantial revenue increase from their GLP-1 receptor agonists, emphasizing the demand for effective management solutions. Additionally, Medtronic is focusing on technological solutions for obesity management, showcasing advancements in obesity-related medical devices. Meanwhile, Zafgen's recent clinical trials highlight promising results for its weight-loss drug candidates. Over the past two years, the market valuation for companies like Amgen and AbbVie has significantly risen, attributed to novel therapies and public health initiatives addressing the obesity epidemic in the US. Legislative measures aimed at increasing access to obesity treatments are also evolving, thereby potentially influencing market dynamics ahead.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 816.9(USD Million) |
| MARKET SIZE 2024 | 871.5(USD Million) |
| MARKET SIZE 2035 | 1785.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.735% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Bristol Myers Squibb, Eli Lilly, Medtronic, Zafgen, Novo Nordisk, Pfizer, Amgen, AbbVie, Allergan, Sanofi, GSK |
| SEGMENTS COVERED | Type, End User, Treatment Method, Distribution Channel |
| KEY MARKET OPPORTUNITIES | Innovative weight loss technologies, Personalized nutrition plans, Digital health solutions, Bariatric surgery advancements, Comprehensive obesity prevention programs |
| KEY MARKET DYNAMICS | rising obesity rates, increasing healthcare costs, growing awareness and education, advancements in treatment options, government regulations and policies |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Obesity Management Market is expected to be valued at 871.5 million USD in 2024.
By 2035, the market is expected to reach a value of 1,785.0 million USD.
The expected CAGR for the US Obesity Management Market from 2025 to 2035 is 6.735%.
In 2024, the Surgical Procedures segment holds the largest market size at 320.0 million USD.
The Pharmacotherapy segment is valued at 250.0 million USD in 2024.
By 2035, the Lifestyle Changes segment is expected to reach a market size of 340.0 million USD.
Key players in the market include Bristol Myers Squibb, Eli Lilly, Medtronic, and Novo Nordisk.
The Fitness Programs segment is projected to be valued at 240.0 million USD by 2035.
Key growth drivers include increasing obesity rates and rising awareness about health management.
Challenges include high costs associated with obesity treatments and varying patient compliance rates.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
